ArriVent BioPharma, Inc. 8-K

Accession 0001104659-26-115161

Filing information

CIK: 0001868279
Report date: 2026-10-12
Filing date: 2026-10-13
Form: 8-K
Primary document: tm2627450d1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.